Search clinical trials for: LINK SL versus EnduRo

Total 22 results

Orthopaedische Klinik Koenig-Ludwig-Haus

Unknown

Outcome EnduRo Versus LINK SL Rotating Hinge Knee

Knee Arthrosis,

Germany
Kantonsspital Aarau
ETH Zurich

Completed

Blink Restoration in Patients With Facial Nerve Palsy (NEURO-BLINK)

Facial Nerve Palsy

Switzerland
Brno University Hospital

Completed

Central Venous Catheters in Pediatric Anesthesia and Intensive Care (PEDCVC)

Central Line

Czechia
Centre Chirurgical Marie Lannelongue

Not yet recruiting

Study of the Effectiveness of Central Line Placement Using an Ultraportable Ultrasound Device (K-T-CO)

Medical Imaging

France
National Institute of Mental Health (NIMH)

Terminated

Imaging of CB1 Receptors Using (11C)SD5024

Healthy

United States
Seoul National University Hospital

Completed

Comparison of Hyperemic Efficacy Between Central and Peripheral Adenosine Infusion for Fractional Flow Reserve (FFR) Measurement

Myocardial Ischemia | Coronary Artery Disease

Korea, Republic of
Mikkel Bring Christensen

Recruiting

Postprandial Profiles of Metabolites and Appetite-regulating Hormones in Plasma and Cerebrospinal Fluid

Obesity | Diabetes Mellitus, Type 2

Denmark
Memorial Sloan Kettering Cancer Center

Completed

Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major

Beta Thalassemia Major | Congenital Anemias

United States
B. Braun Melsungen AG

Completed

Gelatines in Pediatric PatientS (GPS)

Treatment of Hypovolemia and Shock

Spain, Bulgaria, Germany, Italy, United Kingdom
Centre Hospitalier Universitaire de Saint Etienne

Withdrawn

Assessing the Impact of Two Methods of Continuous Veno-venous Hemodiafiltration on Time Nursing Work in Intensive Care

Acute Renal Failure
University of Wisconsin, Madison

Completed

Effects of Changes in Fluid Status on Right Ventricular Volumes and Function

Tetralogy of Fallot

United States
Henan Cancer Hospital

Recruiting

Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

SCLC, Extensive Stage

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Evaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast and Placental Model (ZITOPEx)

Zika Virus Infection
Radboud University Medical Center

Completed

Effect of Gelofusine on GLP1-receptor Imaging (GLP1-EX-GELO)

Diabetes Mellitus | Diabetes Mellitus, Non-Insulin-Dependent
University Hospital, Strasbourg, France

Active, not recruiting

Personalized Non-invasive Neuromodulation by rTMS for Chronic and Treatment Resistant Catatonia (RETONIC)

Schizophreniform Catatonia | Treatment Resistant

France
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Active, not recruiting

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast Cancer

United States
AmDerma

Completed

A Study of Econazole Foam 1% in Athlete's Foot

Tinea Pedis | Athlete's Foot

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Completed

A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)

HIV-1 Infection

Kenya, Brazil, South Africa, Uganda, Zimbabwe, India, Malawi, Haiti, Thailand, Peru
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditions

United States
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States
National Cancer Institute (NCI)

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Glioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditions

United States, Puerto Rico, Guam

Search clinical trials for: LINK SL versus EnduRo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations